Arcadia Biosciences (RKDA) Cash from Investing Activities (2014 - 2025)

Arcadia Biosciences has reported Cash from Investing Activities for 12 years, with the latest figure at $250000.0 in Q2 2025.

• For the quarter ending Q2 2025, Cash from Investing Activities fell 94.62% year-over-year to $250000.0; the trailing twelve-month figure through Dec 2025 stood at $750000.0 (down 89.78% YoY), and the FY2025 full-year result was $750000.0, down 89.78% from the prior year.
• Cash from Investing Activities for Q2 2025 stood at $250000.0, down from $500000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $17.4 million in Q2 2021, with the low at -$4.7 million in Q2 2023.
• Historically, Cash from Investing Activities has averaged $1.2 million across 5 years, with a median of $215000.0 in 2024.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 9925.0% — and 2025, when it surged 12400.0%.
• Arcadia Biosciences' Cash from Investing Activities stood at -$70000.0 in 2021, then jumped by 501.43% to $281000.0 in 2022, then tumbled by 81.49% to $52000.0 in 2023, then soared by 4736.54% to $2.5 million in 2024, then slumped by 90.06% to $250000.0 in 2025.
• The last three Cash from Investing Activities figures came in at $250000.0 (Q2 2025), $500000.0 (Q1 2025), and $2.5 million (Q4 2024), per Business Quant data.